Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

Evolution from the Budget Period 1 to Budget Period 2


In BP1, the mid-year 2012 data collection included eight provisional performance measures and 83 data elements.

ASPR extensively analyzed the eight BP1 performance measures and their 83 data elements.  After qualitative and quantitative analysis, ASPR reduced indicators that proved ambiguous or non-informative.  ASPR maintained the eight performance measures but retired over 60 related data elements, which greatly reduced Awardee reporting burden.


During BP2, ASPR realigned the performance measures with the National Health Security Strategy (NHSS) goals and the disaster cycle framework. They also refined the remaining 20 data elements.

Diagram of the word Reuse pointing to the word Refine which is pointing to the word recalibrate.  The word recalibrate is circled.
As a result of the realignment, ASPR re-categorized the eight BP1 performance measures into two program measures for BP2:  medical surge and continuity of healthcare operations, each with seven indicators that relate directly to the eight capabilities outlined in the Health Preparedness Capabilities.
The 2013 Implementation Guidance document defines the medical surge and continuity of healthcare operations program measures.  The Implementation Guidance also outlines a new assessment tool which will begin to evaluate Healthcare Coalition (HCC) development and maturation over time. 
Hierarchical diagram of HPP Program Measures.  At the top there is a box for HPP Program Measures.  Under that, are two boxes:  Medical Surge and Continuity of Healthcare Operations.  Under each of the boxes is a series of four arrows pointing to the right with the following words:  Preparedness, Response, Recovery, Mitigation.


From BP3 through BP5 (EOY 14-16), ASPR will finalize performance targets (program measures) and their incremental milestones (indicators).  To do this, ASPR will use the existing evidence base, refined program measures, and baseline HCC data.
When developing stable milestones and measurement options, ASPR will consider quality improvement techniques, return on investment, priority setting, and root cause analysis. The recalibrated targets and milestones will allow ASPR to monitor Awardee progress and will inform ASPR’s future program improvement, technical assistance, and policy efforts.
For more information on this and other HPP Program Evaluation topics, please refer to the HPP Measure Manual: Implementation Guidance for the HPP Program Measures.  SHARPER welcomes your feedback. Please submit your questions and comments via email at

SHARPER: Science, Healthcare, Preparedness, Evaluation and Research

  • This page last reviewed: July 16, 2014